Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949269-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 1095.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 1094.4;Langerhans cells: 541.7;monocytes: 659.7;NK-cells: 1385.2;T-cells: 544.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 1287.0"	"Group enriched"	"Detected in all"	27	"granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 77.8;HMC-1: 204.6;NB-4: 212.1;U-937: 380.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		26000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	18.0	3.6	1.3	24.2	1.6	1095.6	5.7	2.8	5.1	4.5	1.7	5.7	5.9	4.6	4.8	5.4	10.4	17.7	5.6	1.5	1.4	5.4	12.7	49.3	73.4	2.4	1.4	2.5	3.9	1.0	2.2	4.4	2.0	4.3	5.1	0.2	6.6	2.0	1.9	4.5	13.9	5.0	1.6	148.1	8.7	1.7	1.6	17.3	5.6	4.4	16.4	19.2	5.2	1.4	0.3	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.3	1.7	0.0	0.4	0.0	77.8	204.6	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	2.8	0.0	0.2	2.0	212.1	0.1	0.0	0.2	0.5	7.7	0.1	0.0	0.1	0.3	0.2	0.0	0.1	1.0	0.1	0.0	13.3	0.2	0.1	0.8	0.2	0.5	0.1	0.1	0.2	0.1	380.4	0.1	74.3	3.0	10.4	1287.0	3.4	720.2	3.7	186.8	904.7	28.4	3.9	38.8	531.2	342.2	655.3	3.5	7.2	123.0	600.8	1.3	1.6	2.8	5.1	1.5	1.4	2.4	1.4	2.0	1.6	1.6	1.4	8.1	9.6	14.1	0.0	14.5	22.8	0.3	0.0	0.0	0.0	2.5	2.4	1.4	4.3	0.6	0.0	0.0	0.2	1094.4	0.3	0.0	1.3	0.0	1.3	0.7	3.2	0.0	46.7	0.0	3.7	0.1	5.2	11.2	1.2	60.0	0.0	11.0	3.8	1.4	0.0	0.0	0.1	0.0	16.2	541.7	0.0	0.0	61.9	24.9	1.9	659.7	0.0	1385.2	0.0	0.1	0.2	0.1	0.0	90.9	0.1	0.4	2.3	2.2	0.0	0.0	2.2	3.6	0.0	0.2	0.5	23.9	1.1	544.5	0.0	0.6	0.6
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 195.3;lymphoid tissue: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4199.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4199.5"	"Group enriched"	"Detected in some"	5	"LHCN-M2: 17.2;U-87 MG: 67.1"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	69.6	10.0	3.8	166.0	4.4	195.3	5.3	4.1	8.7	8.2	5.7	4.6	3.1	3.7	0.5	8.9	15.4	28.6	7.5	3.6	8.1	4.5	21.4	50.8	12.7	15.2	8.2	2.4	11.2	5.1	3.5	45.1	11.9	3.1	3.3	2.6	4.1	2.3	1.8	1.3	5.2	42.9	8.6	129.2	5.4	2.2	9.9	8.4	3.1	22.8	10.3	66.9	2.7	18.2	0.5	0.8	0.3	0.4	1.0	2.1	0.5	0.2	0.0	0.5	2.0	0.3	0.7	1.2	0.6	0.0	3.9	0.4	0.0	0.0	0.1	0.1	0.0	0.7	0.9	1.0	6.0	0.3	0.5	4.8	0.2	1.8	1.8	9.2	0.0	0.3	0.1	0.6	17.2	0.9	0.1	0.3	0.4	0.3	0.7	0.3	0.7	0.0	1.5	0.5	0.2	0.3	0.6	0.1	0.5	0.2	1.0	1.1	1.0	2.0	0.4	0.1	3.5	0.2	0.0	0.5	67.1	1.7	0.1	317.1	759.9	204.9	1.6	319.7	1.5	0.7	1.0	0.7	174.1	1.0	1.0	1.2	4199.5	0.4	201.8	8.1	1.3	420.3	3.8	4.4	4.1	8.7	3.6	8.1	15.2	8.2	11.9	8.6	9.9	18.2	0.1	16.0	25.7	0.0	1.8	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.2	0.0	15.5	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.8	0.0	0.1	6.3	0.0	2.5	0.2	0.0	1.6	4.7	0.5	0.1	26.5	0.0	2.5	2.1	119.6	0.0	0.1	0.0	0.0	215.3	4.7	2.0	0.3	178.5	0.0	3.7	89.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	8.8	0.3	6.6	0.6	0.8	0.6	0.8	0.2	0.0	3.0	2.5	0.0	0.0	0.1
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 198.2;skin 1: 61.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	2.9	0.1	11.5	2.2	0.1	0.4	0.8	0.1	0.5	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	198.2	2.3	0.5	0.1	0.1	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.1	0.8	0.5	0.0	7.6	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.2	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991960-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 90.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 495.7;Kupffer cells: 207.9;Langerhans cells: 1083.3;Macrophages: 210.8;Pancreatic endocrine cells: 211.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 6.4;pons: 1.9"	"Immune cell enriched"	"Detected in some"	26	"neutrophil: 377.5"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 377.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 469.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	27000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	19.7	5.9	0.2	35.5	0.7	52.8	3.7	0.3	6.4	10.3	1.9	29.7	0.8	2.5	3.5	41.2	17.7	5.3	4.0	0.2	0.5	16.0	11.6	30.8	3.3	0.5	0.4	1.2	3.7	0.3	0.8	20.1	1.9	2.3	43.7	0.1	7.9	2.2	1.2	30.7	4.6	3.4	0.3	90.1	33.0	0.5	0.7	7.4	1.9	2.9	38.5	6.2	20.5	0.3	7.3	0.9	0.0	0.0	0.9	1.2	0.8	0.0	0.2	0.0	0.1	7.7	0.2	0.1	14.7	0.0	0.3	2.9	0.0	0.5	0.0	469.8	0.4	0.1	0.1	4.0	2.5	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	60.4	0.0	0.0	0.0	0.0	24.0	1.7	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	1.1	0.4	7.2	0.2	0.0	0.3	0.0	0.5	0.2	0.0	0.1	4.3	0.0	0.0	2.3	0.0	0.0	0.9	0.0	14.5	0.0	0.0	0.0	377.5	0.2	0.1	0.2	5.9	1.5	0.2	0.7	0.3	6.4	0.2	0.5	0.5	0.4	1.9	0.3	0.7	0.3	1.2	6.4	1.1	0.0	1.7	147.9	13.5	2.0	495.7	0.0	0.5	0.4	0.6	10.0	0.3	1.8	0.0	1.2	1.2	23.8	5.9	15.0	2.8	14.5	1.5	4.4	6.7	2.7	0.0	8.3	36.3	6.1	18.3	8.0	2.5	0.0	3.6	16.2	5.8	0.0	0.0	117.4	0.0	207.9	1083.3	4.0	0.3	210.8	32.0	0.0	3.5	0.0	0.0	0.0	0.0	211.0	26.8	0.0	1.6	20.4	0.0	0.7	2.2	0.0	6.6	0.7	3.8	0.7	2.2	38.1	84.0	27.8	2.7	0.4	26.8	14.4
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 376.0;lymphoid tissue: 105.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.1;thalamus: 4.8"	"Immune cell enriched"	"Detected in some"	127	"neutrophil: 272.2"	"Lineage enriched"	"Detected in single"	341	"granulocytes: 272.2"	"Cell line enriched"	"Detected in some"	13	"NB-4: 360.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	61000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	19.5	0.6	0.5	61.9	0.8	376.0	8.2	0.4	3.1	2.9	0.8	5.7	11.6	1.0	0.0	2.2	2.2	3.0	3.2	0.3	0.9	2.6	3.8	21.1	103.2	0.8	0.5	0.8	1.6	0.1	1.1	2.0	0.7	1.9	3.4	0.6	3.6	0.4	0.7	3.2	12.4	1.9	0.4	105.3	11.3	1.3	4.8	17.0	2.1	0.9	36.5	12.0	1.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.3	28.8	0.0	0.3	0.4	0.0	1.4	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	4.0	0.0	360.6	0.8	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.6	0.6	0.0	0.6	0.0	3.7	0.3	1.2	0.3	10.3	10.9	0.1	0.3	0.3	0.2	0.2	0.1	0.8	0.2	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	272.2	0.0	0.3	0.0	0.0	0.5	0.5	0.8	0.4	3.1	0.3	0.9	0.8	0.5	0.7	0.4	4.8	0.2	0.7	0.0	5.5	0.0	3.9	34.3	0.1	61.5	0.0	3.8	0.5	2.0	0.4	1.5	0.9	0.0	8.4	1.5	2.0	0.0	0.0	0.8	0.9	0.0	0.1	7.2	0.0	0.0	0.1	1.8	2.4	2.5	0.0	0.1	1.3	0.2	0.0	0.0	260.1	3.3	0.2	0.5	0.0	1.3	606.0	0.3	0.0	230.6	56.9	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	0.0	0.3	6.9	5.3	0.0	0.2	45.5	6.7	11.2	0.2	28.1	1.9	3.4	0.3	0.0	0.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	582.3	54.3	41.7	1245.8	45.6	35382.0	70.0	43.4	88.0	5650.6	45.5	55.2	15.4	23.1	5.5	24565.6	236.1	99.0	121.1	40.9	42.7	103.0	176.7	1061.7	29.5	47.7	44.8	25.8	52.0	9.6	41.7	205.8	50.7	43.1	14.7	5.6	3988.2	5.0	48.5	267.3	47.7	430.2	44.2	3239.5	93.8	16.2	45.5	281.3	48.8	174.8	8952.6	561.9	11166.4	46.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.7	45.6	43.4	88.0	40.9	42.7	47.7	44.8	50.7	44.2	45.5	46.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.1	9.7	7.3	225.0	7.1	157.1	100.6	9.1	21.3	105.7	11.1	151.0	278.6	42.3	5.3	10.1	22.4	352.3	12.5	7.3	11.1	621.2	34022.4	570.7	37.0	20.9	14.4	5.4	201.0	5.2	9.1	26.6	15.8	12.6	178.8	2.6	33.6	140.5	3.7	8.2	760.9	75.7	12.2	313.6	282.5	3.0	16.2	15.0	23.0	11.9	25.2	55.8	9.1	16.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.3	7.1	9.1	21.3	7.3	11.1	20.9	14.4	15.8	12.2	16.2	16.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7